dr. ott discusses ipilimumab and nivolumab in melanoma
Published 6 years ago • 883 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
1:57
dr. luke discusses the controversy surrounding ipilimumab/nivolumab combo in melanoma
-
3:24
ipilimumab side effect management in melanoma
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
1:17
dr. shoushtari on the role of nivolumab and ipilimumab in mucosal melanoma
-
6:21
new long-term data 'clearly favor' combination ipilimumab/nivolumab in melanoma
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
1:15
dr. postow on nivolumab combined with ipilimumab in melanoma
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
1:02
dr. hodi on nivolumab in combination with ipilimumab for advanced melanoma
-
2:02
dr. jedd wolchok on concurrent ipilimumab and nivolumab in advanced melanoma
-
1:00
dana monroe discusses ipilimumab's side effects
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
2:11
dr. long on rationale for nivolumab/ipilimumab in patients with melanoma who have brain mets
-
3:16
melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better pfs
-
3:59
checkmate 067 - combined nivolumab and ipilimumab